Emily Fitzmeyer

Fitz earned her BA in biology from Saint Anselm College where she studied bacteriophage as potential antibiotic alternatives. Upon receiving her degree she worked as a postbac at Rocky Mountain Laboratories studying the interactions between emerging flaviviruses and the innate immune response. She joined the Ebel lab in March 2020 where she currently works on SARS-CoV-2 surveillance efforts. She is interested in studying virus evolution, specifically what evolutionary factors govern virus emergence and pathogenicity.